23.04 USD
-0.11 (-0.48%)
23.04 USD
0 (0%)
Taking everything into account, PRVA scores 4 out of 10 in our fundamental rating. PRVA was compared to 100 industry peers in the Health Care Providers & Services industry. PRVA has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, PRVA is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year PRVA was profitable.
In the past year PRVA had a positive cash flow from operations.
In multiple years PRVA reported negative net income over the last 5 years.
PRVA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
PRVA has a Return On Assets of 1.34%. This is comparable to the rest of the industry: PRVA outperforms 53.47% of its industry peers.
PRVA's Return On Equity of 2.56% is in line compared to the rest of the industry. PRVA outperforms 57.43% of its industry peers.
PRVA has a Return On Invested Capital (2.45%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| ROIC | 2.45% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of PRVA (0.89%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of PRVA has declined.
With a Operating Margin value of 1.38%, PRVA perfoms like the industry average, outperforming 45.54% of the companies in the same industry.
PRVA's Operating Margin has declined in the last couple of years.
PRVA's Gross Margin of 10.17% is on the low side compared to the rest of the industry. PRVA is outperformed by 74.26% of its industry peers.
In the last couple of years the Gross Margin of PRVA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.38% | ||
| PM (TTM) | 0.89% | ||
| GM | 10.17% |
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRVA is destroying value.
The number of shares outstanding for PRVA has been increased compared to 1 year ago.
PRVA has more shares outstanding than it did 5 years ago.
There is no outstanding debt for PRVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
PRVA has an Altman-Z score of 4.40. This indicates that PRVA is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.40, PRVA belongs to the best of the industry, outperforming 80.20% of the companies in the same industry.
There is no outstanding debt for PRVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.4 |
ROIC/WACC0.27
WACC8.97%
2.3 Liquidity
PRVA has a Current Ratio of 1.67. This is a normal value and indicates that PRVA is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.67, PRVA is doing good in the industry, outperforming 64.36% of the companies in the same industry.
A Quick Ratio of 1.67 indicates that PRVA should not have too much problems paying its short term obligations.
The Quick ratio of PRVA (1.67) is better than 69.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
PRVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.00%, which is quite impressive.
PRVA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.43% yearly.
PRVA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.01%.
PRVA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.17% yearly.
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%
3.2 Future
The Earnings Per Share is expected to grow by 69.59% on average over the next years. This is a very strong growth
PRVA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.73% yearly.
EPS Next Y22%
EPS Next 2Y70.67%
EPS Next 3Y69.59%
EPS Next 5YN/A
Revenue Next Year20.28%
Revenue Next 2Y14.98%
Revenue Next 3Y13.19%
Revenue Next 5Y2.73%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 177.23, which means the current valuation is very expensive for PRVA.
Compared to the rest of the industry, the Price/Earnings ratio of PRVA is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.19, PRVA is valued quite expensively.
With a Price/Forward Earnings ratio of 71.90, PRVA can be considered very expensive at the moment.
PRVA's Price/Forward Earnings is on the same level as the industry average.
PRVA is valuated expensively when we compare the Price/Forward Earnings ratio to 23.92, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 177.23 | ||
| Fwd PE | 71.9 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PRVA indicates a slightly more expensive valuation: PRVA is more expensive than 62.38% of the companies listed in the same industry.
PRVA's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.6 | ||
| EV/EBITDA | 64.17 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PRVA's earnings are expected to grow with 69.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)8.06
PEG (5Y)23.84
EPS Next 2Y70.67%
EPS Next 3Y69.59%
5. Dividend
5.1 Amount
No dividends for PRVA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
23.04
-0.11 (-0.48%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.68%
Inst Owner Change0.02%
Ins Owners1.85%
Ins Owner Change0.2%
Market Cap2.83B
Revenue(TTM)2.04B
Net Income(TTM)18.17M
Analysts84.44
Price Target32.18 (39.67%)
Short Float %2.62%
Short Ratio4.03
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-34.97%
Min EPS beat(2)-60.96%
Max EPS beat(2)-8.97%
EPS beat(4)0
Avg EPS beat(4)-37.14%
Min EPS beat(4)-60.96%
Max EPS beat(4)-8.97%
EPS beat(8)0
Avg EPS beat(8)-42.01%
EPS beat(12)3
Avg EPS beat(12)40.52%
EPS beat(16)6
Avg EPS beat(16)56.54%
Revenue beat(2)2
Avg Revenue beat(2)11.82%
Min Revenue beat(2)5.73%
Max Revenue beat(2)17.91%
Revenue beat(4)4
Avg Revenue beat(4)8.08%
Min Revenue beat(4)0.75%
Max Revenue beat(4)17.91%
Revenue beat(8)8
Avg Revenue beat(8)5.39%
Revenue beat(12)10
Avg Revenue beat(12)0.33%
Revenue beat(16)10
Avg Revenue beat(16)-9.08%
PT rev (1m)0.48%
PT rev (3m)3.18%
EPS NQ rev (1m)-2.78%
EPS NQ rev (3m)-43.41%
EPS NY rev (1m)-1.5%
EPS NY rev (3m)-19.32%
Revenue NQ rev (1m)0.61%
Revenue NQ rev (3m)8.01%
Revenue NY rev (1m)0.79%
Revenue NY rev (3m)4.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 177.23 | ||
| Fwd PE | 71.9 | ||
| P/S | 1.39 | ||
| P/FCF | 25.6 | ||
| P/OCF | 25.6 | ||
| P/B | 4 | ||
| P/tB | 7.67 | ||
| EV/EBITDA | 64.17 |
EPS(TTM)0.13
EY0.56%
EPS(NY)0.32
Fwd EY1.39%
FCF(TTM)0.9
FCFY3.91%
OCF(TTM)0.9
OCFY3.91%
SpS16.61
BVpS5.77
TBVpS3
PEG (NY)8.06
PEG (5Y)23.84
Graham Number4.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| ROCE | 3.67% | ||
| ROIC | 2.45% | ||
| ROICexc | 5.77% | ||
| ROICexgc | N/A | ||
| OM | 1.38% | ||
| PM (TTM) | 0.89% | ||
| GM | 10.17% | ||
| FCFM | 5.42% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-10.22%
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
F-Score7
Asset Turnover1.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 112.37 | ||
| Cash Conversion | 296.89% | ||
| Profit Quality | 609.36% | ||
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z | 4.4 |
F-Score7
WACC8.97%
ROIC/WACC0.27
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
EPS Next Y22%
EPS Next 2Y70.67%
EPS Next 3Y69.59%
EPS Next 5YN/A
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%
Revenue Next Year20.28%
Revenue Next 2Y14.98%
Revenue Next 3Y13.19%
Revenue Next 5Y2.73%
EBIT growth 1Y114.42%
EBIT growth 3YN/A
EBIT growth 5Y1.07%
EBIT Next Year573.2%
EBIT Next 3Y111.25%
EBIT Next 5Y64.24%
FCF growth 1Y142.02%
FCF growth 3Y26.09%
FCF growth 5Y42.42%
OCF growth 1Y141.5%
OCF growth 3Y25.67%
OCF growth 5Y35.01%
PRIVIA HEALTH GROUP INC / PRVA FAQ
What is the fundamental rating for PRVA stock?
ChartMill assigns a fundamental rating of 4 / 10 to PRVA.
Can you provide the valuation status for PRIVIA HEALTH GROUP INC?
ChartMill assigns a valuation rating of 2 / 10 to PRIVIA HEALTH GROUP INC (PRVA). This can be considered as Overvalued.
Can you provide the profitability details for PRIVIA HEALTH GROUP INC?
PRIVIA HEALTH GROUP INC (PRVA) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for PRVA stock?
The Price/Earnings (PE) ratio for PRIVIA HEALTH GROUP INC (PRVA) is 177.23 and the Price/Book (PB) ratio is 4.
Can you provide the financial health for PRVA stock?
The financial health rating of PRIVIA HEALTH GROUP INC (PRVA) is 7 / 10.